Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Biochemical Bone Marker Market - Dawn or Dusk?

This article was originally published in Clinica

Executive Summary

Biochemical bone marker tests, especially those for bone resorption, are on the brink of being established as a routine tool in the management of osteoporosis. Until two years ago, the new market of resorption tests was one of the fastest growing sectors in immunodiagnostics. Nonetheless, the share prices of the two main players - Metra Biosystems and Ostex International - have reached an all-time low of below $1.00.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts